Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 7/20 | 0.64 |
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | LTA4H | P09960 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.52 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | GCGR | P47871 | 1/20 | 0.48 |
| ▸ | HPGDS | O60760 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17800997 | 0.86 | IDO1 (0.75) | IDO1ASIC3POLBSMN1; SMN2CYP3A4 | |
| SCHEMBL27880327 | 0.80 | IDO1 (0.67) | IDO1ASIC3POLBSMN1; SMN2CYP3A4 | |
| SCHEMBL872238 | 0.78 | IDO1 (0.64) | IDO1ASIC3POLBSMN1; SMN2CYP3A4 | |
| SCHEMBL1951516 | 0.78 | IDO1 (1.00) | IDO1ASIC3POLBSMN1; SMN2CYP3A4 | |
| SCHEMBL17782163 | 0.78 | ASIC3 (1.00) | IDO1ASIC3POLBSMN1; SMN2CYP3A4 | |
| SCHEMBL14705340 | 0.78 | IDO1 (0.64) | IDO1ASIC3POLBSMN1; SMN2CYP3A4 | |
| SCHEMBL205481 | 0.78 | IDO1 (0.64) | IDO1ASIC3POLBSMN1; SMN2CYP3A4 | |
| SCHEMBL496675 | 0.78 | IDO1 (0.64) | IDO1ASIC3POLBSMN1; SMN2CYP3A4 | |
| SCHEMBL872388 | 0.78 | POLB (1.00) | IDO1ASIC3POLBSMN1; SMN2CYP3A4 | |
| SCHEMBL27577902 | 0.78 | IDO1 (0.91) | IDO1ASIC3POLBSMN1; SMN2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101296731-A | Novel benzopyran derivatives as potassium channel openers | JANSSEN PHARMACEUTICA NV (BE) | 2008-10-29 | — | — | CN | claimed |
| CN-112034929-B | Folding display screen, manufacturing method of folding display screen and terminal equipment | 华为技术有限公司 | 2022-10-18 | — | — | CN | disclosed |
| EP-3032625-B1 | FUEL CELL SEPARATOR | NISSHINBO CHEMICAL INC (JP) | 2020-01-08 | — | — | EP | disclosed |
| EP-3264506-A1 | METHOD FOR PRODUCING A FUEL CELL SEPARATOR | Nisshinbo Chemical Inc. (JP) | 2018-01-03 | — | — | EP | disclosed |
| EP-2458667-B1 | FUEL CELL SEPARATOR | NISSHINBO CHEMICAL INC (JP) | 2017-05-24 | — | — | EP | disclosed |
| EP-2763223-B1 | POROUS SEPARATOR FOR FUEL CELLS | NISSHINBO CHEMICAL INC (JP) | 2016-11-16 | — | — | EP | disclosed |
| EP-3032625-A1 | FUEL CELL SEPARATOR | Nisshinbo Chemical Inc. (JP) | 2016-06-15 | — | — | EP | disclosed |
| US-20160156044-A1 | FUEL CELL SEPARATOR | NISSHINBO CHEMICAL INC. (JP) | 2016-06-02 | — | — | US | disclosed |
| EP-2763223-A1 | POROUS SEPARATOR FOR FUEL CELLS | Nisshinbo Chemical Inc. (JP) | 2014-08-06 | — | — | EP | disclosed |
| US-8372192-B2 | Fuel cell separator | NISSHINBO CHEMICAL INC. (JP) | 2013-02-12 | — | — | US | disclosed |
| US-7838553-B2 | Benzopyran derivatives as potassium channel openers | JANSSEN PHARMACEUTICA NV (BE) | 2010-11-23 | — | — | US | disclosed |
| US-7812183-B2 | Benzopyran derivatives as potassium channel openers | JANSSEN PHARMACEUTICA NV (BE) | 2010-10-12 | — | — | US | disclosed |
| CN-101296731-A | Novel benzopyran derivatives as potassium channel openers | JANSSEN PHARMACEUTICA NV (BE) | 2008-10-29 | — | — | CN | disclosed |
| CN-101296925-A | Novel benzopyran derivatives as potassium channel openers | JANSSEN PHARMACEUTICA NV (BE) | 2008-10-29 | — | — | CN | disclosed |
| EP-1940516-A2 | BENZOPYRAN AND PYRANOPYRIDINE DERIVATIVES AS POTASSIUM CHANNEL OPENERS | Janssen Pharmaceutica, N.V. (BE) | 2008-07-09 | — | — | EP | disclosed |
| EP-1937669-A1 | NOVEL BENZOPYRAN DERIVATIVES AS POTASSIUM CHANNEL OPENERS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-07-02 | — | — | EP | disclosed |
| US-20070072832-A1 | NOVEL BENZOPYRAN DERIVATIVES AS POTASSIUM CHANNEL OPENERS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-03-29 | — | — | US | disclosed |
| WO-2007027959-A1 | NOVEL BENZOPYRAN DERIVATIVES AS POTASSIUM CHANNEL OPENERS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-03-08 | — | — | WO | disclosed |
| WO-2007027780-A2 | BENZOPYRAN AND PYRANOPYRIDINE DERIVATIVES AS POTASSIUM CHANNEL OPENERS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-03-08 | — | — | WO | disclosed |
| US-20070049556-A1 | NOVEL BENZOPYRAN DERIVATIVES AS POTASSIUM CHANNEL OPENERS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049556-A1 | NOVEL BENZOPYRAN DERIVATIVES AS POTASSIUM CHANNEL OPENERS | KCNJ2, KCNN1, KCNN3 | IDO1 4077/4885ASIC3 179/4885POLB 4587/4885 |
| US-20070072832-A1 | NOVEL BENZOPYRAN DERIVATIVES AS POTASSIUM CHANNEL OPENERS | KCNJ2, KCNN1, KCNN3 | IDO1 4077/4885ASIC3 179/4885POLB 4587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.